Varian receives FDA exemption for Radiate-VT trial
January 19, 2023 -- Varian, a Siemens Healthineers company, has secured an investigational device exemption by the U.S. Food and Drug Administration (FDA) for the Radiate-VT clinical trial. Read More
MRI guidance beats CT for prostate cancer stereotactic body radiotherapy
January 12, 2023 -- MRI-guided stereotactic body radiotherapy outperforms CT guidance when it comes to reducing toxic effects of the treatment, according to a study published January 12 in JAMA Oncology. Read More
New technology visualizes radiation therapy dose in real-time
January 11, 2023 -- U.S. researchers say they have developed a new 3D imaging prototype for visualizing real-time radiation dose in patients undergoing radiation therapy. They published the results of their study on January 2 in Nature Biotechnology. Read More
RaySearch marks milestone in Japan
January 11, 2023 -- RaySearch Laboratories said it passed an installation milestone in Japan, with more than 200 radiotherapy centers in the country now using its RayStation proton therapy system. Read More
RaySearch secures Ohio State University contract
January 9, 2023 -- RaySearch Laboratories has secured a contract with the Ohio State University Comprehensive Cancer Center Arthur G. James Cancer Hospital and the Richard J. Solove Research Institute for its RayStation proton therapy system, the Varian ProBeam 360. Read More
MRgFUS up to the task for relieving painful bone metastases
January 6, 2023 -- MRI-guided focused ultrasound surgery (MRgFUS) is superior to external-beam radiation therapy for relieving pain in patients with bone metastases, according to Italian research published January 3 in Radiology. Read More
B dot secures Japanese install of its compact proton therapy system
January 5, 2023 -- B dot Medical has inked a contract with a Japanese hospital to install its compact proton therapy system. Read More
Companies ink deal to develop OncoFAP-23
December 14, 2022 -- Philochem has signed agreements with Seibersdorf Laboratories and Isotopia Molecular Imaging to develop its lutetium-177 OncoFAP-23 radiopharmaceutical for cancer treatment. Read More
RaySearch secures $18M Ion Beam Applications order
December 9, 2022 -- RaySearch Laboratories has secured a 17.3-million-euro ($18 million U.S.) order from proton therapy developer Ion Beam Applications (IBA) for its RayStation treatment planning system and its RayCare oncology information system. Read More
Parking fees contribute to cancer patients' financial burden
December 7, 2022 -- Hospital parking fees add to cancer patients' financial burden, and may lead to poorer health outcomes, suggests a Canadian study published December 7 in the Journal of Medical Imaging and Radiation Sciences. Read More
Special Feature
Representation in radiation oncology remains challenging
Radiation oncology has some of the lowest numbers when it comes to female senior faculty representation, according to research published in JAMA Network Open. Read more
VENDOR CONNECT